Transition report pursuant to Rule 13a-10 or 15d-10

COMMITMENTS AND CONTENGENCIES

v3.22.1
COMMITMENTS AND CONTENGENCIES
4 Months Ended
Dec. 31, 2021
COMMITMENTS AND CONTENGENCIES  
COMMITMENTS AND CONTENGENCIES

NOTE 8 – COMMITMENTS AND CONTENGENCIES

 

The Company has certain financial commitments in relation to Research and Development contracts as of December 31, 2021, as follows:

 

The Company is invoiced monthly and quarterly in relation to several Research and Development contracts.

The Company may be obligated to make additional payments related to Research and Development contracts entered into, dependent on the progress and milestones achieved through the programs.

 

 

 

 

Our principal executive office is currently located at 505 Lomas Santa Fe, Suite 160, Solana Beach, California 92075, USA. Our United Kingdom subsidiary, Artelo Biosciences Limited maintains an office at the biohub located at Mereside, Alderly Park, Alderly Edge, Cheshire, SK10 4TG, UK. We do not currently own any properties, laboratories, or manufacturing facilities. The leases for the subsidiaries’ office spaces are month-to-month.